Product Availability Update
Following recent correspondence from the MHRA and a review of our catalogue, certain peptide products have been removed from sale and are no longer available to purchase. Read more
Research Summary
N-Acetyl Epitalon Amidate is a modified Epitalon analogue explored in peptide stability and longevity research models.
Evidence profile
Controlled human evidence
10 cited publications · 1 primary trial
Findings below belong to the studies that reported them. They describe the material and conditions those authors used, not this product, and not an outcome to expect.
Khavinson V et al. · Neuro endocrinology letters · 2002
The study reportedEpitalon therapy in patients with degenerative retinal lesions results in a positive clinical effect in 90% of the cases. The analysis of Epitalon effects suggests that the tetrapeptide participates in the mechanisms of transcription common for the epiphysis and retina.
Araj SK et al. · International journal of molecular sciences · 2025 · PMID 40141333
Al-Dulaimi S et al. · Biogerontology · 2025 · PMID 40908429
Gatta M et al. · Stem cell reviews and reports · 2025 · PMID 40493162
Ullah S et al. · Life sciences · 2025 · PMID 39788414
Yue X et al. · Aging · 2022 · PMID 35413689
Khavinson V et al. · Molecules (Basel, Switzerland) · 2020 · PMID 32019204
Sinjari B et al. · Stem cell reviews and reports · 2020 · PMID 31677028
Sibarov DA et al. · Neuroscience and behavioral physiology · 2007 · PMID 17955380
Khavinson VKh et al. · Bulletin of experimental biology and medicine · 2002 · PMID 12660839
Published studies summarised here concern the specific investigational or pharmaceutical materials and study conditions described by their authors. Their findings are not performance claims for Lucid Peptides material. Citations verified against PubMed on 2026-08-09.